Marianna Skipitari

Dr. Marianna Skipitari

Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
PSPanagiotis Svarnas
Panagiotis Svarnas
MPMichael Poupouzas
Michael Poupouzas
KPKonstantia Papalexopoulou
Konstantia Papalexopoulou
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
CKCHRISTOFOROS A KRONTIRAS
CHRISTOFOROS A KRONTIRAS
This work is devoted to unbuffered and buffered water treatment by means of atmospheric pressure cold plasma of electrical discharges. The interest in the activation of these two liquids by plasma-induced, gaseous-phase chemistry ranges over a wide area of potential applications and interdisciplinary scientific fields. These include biology, medicine, sanitation, environmental restoration, agriculture, etc. Atmospheric pressure cold plasma is here produced in the form of a plasma jet and set into physical contact with the liquid specimens. The operational window of the treatment, in terms of plasma reactivity, is determined by means of UV-NIR optical emission spectroscopy, and the treated liquids are probed in a variety of respects. Evaporation rate, temperature, acidity and basicity, resistivity, and oxidation-reduction potential are measured as a function of the treatment time, either in-situ or ex-situ. The formation of principal reactive oxygen species, i.e., •OH, H2O2 and O2•−, with a plasma jet mean power lower than 400 mW, is eventually demonstrated and their concentration is measured with original methods borrowed from the biology field. The experimental results are linked to reports published over the last ten years, which are compiled in a brief but meaningful review.

21 September 2022 in Journal of Photochemistry and Photobiology A: Chemistry
Verified
Journal Article
Open access
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
PPPolyxeni Papadea
Polyxeni Papadea
AVAthina Varemmenou
Athina Varemmenou
VGVassilios E. Gavriil
Vassilios E. Gavriil
CGChristos D. Georgiou
Christos D. Georgiou

5 January 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
PPPolyxeni Papadea
Polyxeni Papadea
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
AVAthina Varemmenou
Athina Varemmenou
MSMaria Spiliopoulou
Maria Spiliopoulou
Christos GeorgiouChristos Georgiou
Christos Georgiou
The present study uses simple, innovative methods to isolate, characterize and fractionate LDL in its main components for the study of specific oxidations on them that characterize oxidized low-density lipoprotein (oxLDL) status, as it causatively relates to atherosclerosis-associated cardiovascular disease (CVD) risk assessment. These methods are: (a) A simple, relatively time-short, low cost protocol for LDL isolation, to avoid shortcomings of the currently employed ultracentrifugation and affinity chromatography methodologies. (b) LDL purity verification by apoB100 SDS-PAGE analysis and by LDL particle size determination; the latter and its serum concentration are determined in the present study by a simple method more clinically feasible as marker of CVD risk assessment than nuclear magnetic resonance. (c) A protocol for LDL fractionation, for the first time, into its main protein/lipid components (apoB100, phospholipids, triglycerides, free cholesterol, and cholesteryl esters), as well as into LDL carotenoid/tocopherol content. (d) Protocols for the measurement, for the first time, of indicative specific LDL component oxidative modifications (cholesteryl ester-OOH, triglyceride-OOH, free cholesterol-OOH, phospholipid-OOH, apoB100-MDA, and apoB100-DiTyr) out of the many (known/unknown/under development) that collectively define oxLDL status, which contrasts with the current non-specific oxLDL status evaluation methods. The indicative oxLDL status markers, selected in the present study on the basis of expressing early oxidative stress-induced oxidative effects on LDL, are studied for the first time on patients with end stage kidney disease on maintenance hemodialysis, selected as an indicative model for atherosclerosis associated diseases. Isolating LDL and fractionating its protein and main lipid components, as well as its antioxidant arsenal comprised of carotenoids and tocopherols, paves the way for future studies to investigate all possible oxidative modifications responsible for turning LDL to oxLDL in association to their possible escaping from LDL’s internal antioxidant defense. This can lead to studies to identify those oxidative modifications of oxLDL (after their artificial generation on LDL), which are recognized by macrophages and convert them to foam cells, known to be responsible for the formation of atherosclerotic plaques that lead to the various CVDs.

11 October 2021 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
Eirini KostopoulouEirini Kostopoulou
Eirini Kostopoulou
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
PPPolyxeni Papadea
Polyxeni Papadea
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
AGAndrea Paola Rojas Gil
Andrea Paola Rojas Gil
Christos GeorgiouChristos Georgiou
Christos Georgiou

3 June 2023 in Redox Biology
Verified
Journal Article
Open access
PPPolyxeni Papadea
Polyxeni Papadea
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
AVAthina Varemmenou
Athina Varemmenou
MPMarios Papasotiriou
Marios Papasotiriou
Christos GeorgiouChristos Georgiou
Christos Georgiou
Maintenance peritoneal dialysis (PD) is commonly associated with cardiovascular diseases (CVDs), whose risk is assessed via LDL-C. Nonetheless, oxidized LDL (oxLDL), as being a key component of atherosclerotic lesions, could be also associated with atherosclerosis and related CVDs. However, its predictive value for CVDs risk assessment is subject of research studies due to the lack of specific methods to measure oxLDL status from its individual lipid/protein components. In the present study, six novel oxLDL markers, representative of certain oxidative modifications on the LDL protein and lipid components, are measured in atherosclerosis-prone PD patients (39) versus those in chronic kidney disease patients (61) under hemodialysis (HD) and healthy controls (40). LDL from serum of PD, HD and control subjects were isolated and fractionated into cholesteryl esters, triglycerides, free cholesterol, phospholipids and apolipoprotein B100 (apoB100). Subsequently the oxLDL markers cholesteryl ester hydroperoxides (-OOH), triglyceride-OOH, free cholesterol-OOH, phospholipid-OOH, apoB100 malondialdehyde and apoB100 dityrosines were measured. LDL carotenoid levels and LDL particle serum concentration were also measured. The levels of all oxLDL lipid-OOH markers were significantly elevated in PD patients versus control, while the levels of cholesteryl ester-/triglyceride-/free cholesterol-OOH were significantly elevated in PD versus HD patients, regardless of patients' underlying medical conditions, sex, age, PD type, clinical biochemical markers and medication. It should be noted that all fractionated lipid-OOH levels were inversely correlated with LDL-P concentration, while LDL-P concentration was not correlated with LDL-C in PD patients. Moreover, LDL carotenoids were significantly lower in PD patients versus control. The increased levels of oxLDL status specific markers in both PD and HD patients (compared to control), support a potential prognostic value of oxLDL regarding CVD risk assessment in both patient groups. Lastly, the study introduces the oxLDL peroxidation markers free cholesterol-OOH and cholesteryl ester-OOH as complementary to LDL-P number, and as possible alternatives to LDL-C.

22 September 2022 in Radiation
Verified
Journal Article
Open access
PDF file
Christos GeorgiouChristos Georgiou
Christos Georgiou
EKElectra Kalaitzopoulou
Electra Kalaitzopoulou
Marianna SkipitariMarianna Skipitari
Marianna Skipitari
PPPolyxeni Papadea
Polyxeni Papadea
AVAthina Varemmenou
Athina Varemmenou
ACAlkiviadis-Constantinos Cefalas
Alkiviadis-Constantinos Cefalas
The critical arguments for radiofrequency radiation exposure limits are currently based on the principle that radio frequencies (RF) and electromagnetic fields (EMFs) are non-ionising, and their exposure limits are even 100-fold lower than those emitted from the Sun in the whole RF-EMF spectrum. Nonetheless, this argument has been challenged by numerous experimental and theoretical studies on the diverse biological effects of RF-EMF at much lower power density (W/m2) levels than today’s exposing limits. On the other hand, less attention has been given to counterarguments based on the differences in the physics concepts underlying man-made versus natural electromagnetic radiation (EMR) and on the fact that man’s biology has been adapted to the natural EMR levels reaching Earth’s surface at single EMF wavelengths, which are the natural limits of man’s exposure to EMFs. The article highlights the main points of interaction of natural and man-made radiation with biomatter and reveals the physical theoretical background that explains the effects of man-made microwave radiation on biological matter. Moreover, the article extends its analysis on experimental quantum effects, establishing the “ionising-like” effects of man-made microwave radiation on biological matter.